Based on the expanding set of applications for hyperpolarized carbon-13 (HP-13 C) MRI, this work aims to communicate standardized methodology implemented at the University of California, San Francisco, as a primer for conducting reproducible metabolic imaging studies of the prostate and brain. Current state-of-the-art HP-13 C acquisition, data processing/reconstruction and kinetic modeling approaches utilized in patient studies are presented together with the rationale underpinning their usage. Organized around spectroscopic and imaging-based methods, this guide provides an extensible framework for handling a variety of HP-13 C applications, which derives from two examples with dynamic acquisitions: 3D echo-planar spectroscopic imaging of the human prostate and frequency-specific 2D multislice echo-planar imaging of the human brain. Details of sequence-specific parameters and processing techniques contained in these examples should enable investigators to effectively tailor studies around individual-use cases. Given the importance of clinical integration in improving the utility of HP exams, practical aspects of standardizing data formats for reconstruction, analysis and visualization are also addressed alongside open-source software packages that enhance institutional interoperability and validation of methodology. To facilitate the adoption and further development of this methodology, example datasets and analysis pipelines have been made available in the supporting information.
Keywords: 13C; Brain cancer; hyperpolarized MRI; metabolic imaging; prostate cancer.
© 2020 John Wiley & Sons, Ltd.
Technique development of 3D dynamic CS-EPSI for hyperpolarized 13 C pyruvate MR molecular imaging of human prostate cancer.Magn Reson Med. 2018 Nov;80(5):2062-2072. doi: 10.1002/mrm.27179. Epub 2018 Mar 25. Magn Reson Med. 2018. PMID: 29575178 Free PMC article.
Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients.Magn Reson Med. 2019 Apr;81(4):2702-2709. doi: 10.1002/mrm.27549. Epub 2018 Oct 30. Magn Reson Med. 2019. PMID: 30375043 Free PMC article.
Radial spectroscopic MRI of hyperpolarized [1-(13) C] pyruvate at 7 tesla.Magn Reson Med. 2014 Oct;72(4):986-95. doi: 10.1002/mrm.25004. Epub 2013 Nov 1. Magn Reson Med. 2014. PMID: 24186845 Free PMC article.
Magnetic resonance imaging with hyperpolarized agents: methods and applications.Phys Med Biol. 2017 Jul 7;62(13):R81-R123. doi: 10.1088/1361-6560/aa6be8. Epub 2017 Apr 6. Phys Med Biol. 2017. PMID: 28384123 Free PMC article. Review.
Hyperpolarized [13C]-2-hydroxyethylpropionate.2008 Jan 31 [updated 2008 Mar 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. Molecular Imaging and Contrast Agent Database (MICAD). 2004–2013. PMID: 20641315 Free Books & Documents. Review.
- Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci. 2003;100(18):10158-10163.
- Golman K, in't Zandt R, Thaning M. Real-time metabolic imaging. Proc Natl Acad Sci. 2006;103:11270-11275.
- Nelson SJ, Kurhanewicz J, Vigneron DB, et al. Metabolic imaging of patients with prostate cancer using hyperpolarized [1-C-13]pyruvate. Sci Transl Med. 2013;5(198):198ra108.
- Park I, Larson PEZ, Gordon JW, et al. Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies. Magn Reson Med. 2018;80:864-873.
- Mammoli D, Gordon J, Autry A, et al. Kinetic modeling of hyperpolarized carbon-13 pyruvate metabolism in the human brain. IEEE Trans Med Imaging. 2019;0062(c):1.
- P41 EB013598/EB/NIBIB NIH HHS/United States
- U01EB026412/GF/NIH HHS/United States
- U01 EB026412/EB/NIBIB NIH HHS/United States
- R01 CA183071/CA/NCI NIH HHS/United States
- U01CA232320/GF/NIH HHS/United States